Company page

Cullinan Therapeutics, Inc.

Cullinan Therapeutics, Inc. (ticker: CGEM) is a publicly traded company based in the United States, with a market capitalization of approximately $923.7 million. The company focuses on developing innovative therapies to address unmet medical needs. Its strategic initiatives aim to advance its pipeline of potential treatments in the biopharmaceutical sector.